Home > News > Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
July 24th, 2006
Dr. Shelly Gunn Joins CombiMatrix Molecular Diagnostics
Abstract: Acacia Research Corporation (Nasdaq:CBMX)(Nasdaq:ACTG) announced today that Dr. Shelly Gunn, M.D., Ph.D., has joined CombiMatrix Molecular Diagnostics (CMDX) as its Medical Director.
Source:businesswire
Bookmark:
Announcements
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Atomic-Scale Investigations Solve Key Puzzle of LED Efficiency: MIT and Brookhaven Lab scientists use electron microscopy imaging techniques to settle a solid-state controversy and raise new experimental possibilities May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
Rice unveils method for tailoring optical processors: Arranging nanoparticles in geometric patterns allows for control of light with light May 21st, 2013